Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Origin Bancorp
OBK
$1.69B
| $2.28M | ﹤0.01% |
65,966
-19,727
| -23% | -$731K |
|
2777
CALL
Roku
ROKU
$21.5B
| $2.27M | ﹤0.01% |
22,700
+21,000
| +1,235% | +$1.94M |
|
|
SMA
2778
SmartStop Self Storage REIT
SMA
$1.86B
| $2.27M | ﹤0.01% |
60,243
-29,927
| -33% | -$1.09M |
|
2779
Nurix Therapeutics
NRIX
$2.41B
| $2.26M | ﹤0.01% |
245,095
-9,775
| -4% | -$102K |
|
2780
AGNC Investment
AGNC
$12.4B
| $2.26M | ﹤0.01% |
230,936
-171,619
| -43% | -$1.66M |
|
2781
CALL
Liberty Energy
LBRT
$3.05B
| $2.25M | ﹤0.01% |
+182,700
| New | +$2.11M |
|
2782
CALL
Norfolk Southern
NSC
$75.4B
| $2.25M | ﹤0.01% |
+7,500
| New | +$2.08M |
|
|
BELFB
2783
Bel Fuse Inc Class B
BELFB
$3.87B
| $2.25M | ﹤0.01% |
15,966
-5,680
| -26% | -$724K |
|
|
HUT
2784
CALL
Hut 8
HUT
$12.1B
| $2.25M | ﹤0.01% |
+64,500
| New | +$1.64M |
|
2785
PUT
Consolidated Edison
ED
$40.1B
| $2.24M | ﹤0.01% |
+22,300
| New | +$2.24M |
|
2786
ASP Isotopes
ASPI
$504M
| $2.24M | ﹤0.01% |
232,364
+56,416
| +32% | +$520K |
|
|
LENZ
2787
LENZ Therapeutics
LENZ
$166M
| $2.23M | ﹤0.01% |
47,826
+2,016
| +4% | +$74.1K |
|
2788
LGI Homes
LGIH
$1.27B
| $2.22M | ﹤0.01% |
42,902
-13,209
| -24% | -$770K |
|
2789
Granite Ridge Resources
GRNT
$627M
| $2.21M | ﹤0.01% |
408,908
+125,343
| +44% | +$683K |
|
2790
Grindr
GRND
$3.08B
| $2.21M | ﹤0.01% |
147,151
-13,273
| -8% | -$233K |
|
2791
ZipRecruiter
ZIP
$321M
| $2.21M | ﹤0.01% |
523,734
-22,791
| -4% | -$107K |
|
2792
Oric Pharmaceuticals
ORIC
$1.15B
| $2.21M | ﹤0.01% |
184,091
+41,410
| +29% | +$436K |
|
2793
Sylvamo
SLVM
$1.49B
| $2.21M | ﹤0.01% |
49,950
-16,465
| -25% | -$763K |
|
2794
Alight
ALIT
$447M
| $2.2M | ﹤0.01% |
33,710
-14,781
| -30% | -$1.31M |
|
2795
CALL
XPO
XPO
$23.5B
| $2.2M | ﹤0.01% |
+17,000
| New | +$2.21M |
|
2796
Sportradar
SRAD
$4.3B
| $2.19M | ﹤0.01% |
81,563
-1,215,547
| -94% | -$36M |
|
2797
CALL
Moody's
MCO
$82.8B
| $2.19M | ﹤0.01% |
4,600
| – | – |
|
|
BLSH
2798
Bullish
BLSH
$3.3B
| $2.19M | ﹤0.01% |
+34,413
| New | +$2.11M |
|
|
JBGS
2799
JBG SMITH
JBGS
$818M
| $2.19M | ﹤0.01% |
98,250
-63,008
| -39% | -$1.3M |
|
2800
National Healthcare
NHC
$3.53B
| $2.19M | ﹤0.01% |
17,985
-6,071
| -25% | -$655K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.